We are excited to announce that our co-founders, Rebecca Stjernberg Bejhed and Christopher Blacker, recently shared some of our latest...

Advancing IV therapy through collaboration: a visit to CHUC hospital

ReLink achieves registered trademark status in India, strengthening global commitment to patient safety

Rebecca Bejhed Returns from NIVAS Conference with Valuable Insights

Interlinked AB has reached a significant milestone with the FDA registration of our innovative solution designed to improve healthcare

As May wraps up, we are thrilled to share some key highlights from an incredibly productive month at Interlinked AB!

Interlinked COO Rebecca Bejhed is back from the Infusion Nurses Society 2024

Interlinked CEO Katarina Hedbeck moderates the discussion on Developing Your Clinical Trial Strategy – Meeting Compliance

Interlinked thanks KTH Innovation for their steadfast support from the very beginning.

Strengthening Our Core: A Successful Collaboration in Cork

Interlinked is engaging with a university closely connected with a leading hospital.

Interlinked is into discussions with our sales collaborators, all focused on introducing ReLink to the Irish market.

Interlinked is thrilled to reflect on a successful week at Arab Health 2024.

Interlinked is proud to share that two of our co-founders, recently returned to Karolinska Institutet as guest lecturers.

Business Focus Magazine has featured our company's journey from conceptualization to reality in their latest publication.